Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection is a research paper published in Molecular Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of Michigan
Grant: T32‐GM113900
Cancer Research UK
Grant: A27412
Cancer Research UK
Grant: 19278
Cancer Research UK
Grant: A20465
NCI NIH HHS
Grant: P30 CA046592
NIGMS NIH HHS
Grant: T32 GM113900
NCI NIH HHS
Grant: P30 CA008748
Cancer Research UK
Grant: A25254
Menarini Silicon Biosystems
Manchester Biomedical Research Centre
AstraZeneca
Fashion Footwear Association of New York
National Institute for Health Research (NIHR)
Department of Health
FWCI
1.50
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Miniaturized protein profiling permits targeted signaling pathway analysis in individual circulating tumor cells to improve personalized treatment
Additional file 1 of Miniaturized protein profiling permits targeted signaling pathway analysis in individual circulating tumor cells to improve personalized treatment